Top Banner
ExL Pharma: Billing compliance DARSHAN KULKARNI, PHARM.D, MS, ESQ. KULKARNI LAW FIRM
36

Billing Compliance for Clinical Trials

Jul 29, 2015

Download

Health & Medicine

Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Billing Compliance for Clinical Trials

ExL Pharma:Billing compliance

DARSHAN KULKARNI, PHARM.D, MS, ESQ.

KULKARNI LAW FIRM

Page 2: Billing Compliance for Clinical Trials

Disclaimer

• Not legal advice• May not be specific to your situation• Does not create an attorney/ client relationship

Kulkarni Law Firm, PC

2

Page 3: Billing Compliance for Clinical Trials

Legal & Regulatory Sections

Kulkarni Law Firm, PC

3

False Claims Act

Anti-Kickback Law

Stark Law

Park Doctrine

Page 4: Billing Compliance for Clinical Trials

Outline

FMV:

FCA

Anti-Kickback

Stark

Sunshine Act

Kulkarni Law Firm, PC

Page 5: Billing Compliance for Clinical Trials

False Claims ACT• FCA• AKL• Stark• Park Doctrine• Planning• Future

Page 6: Billing Compliance for Clinical Trials

What Matters - FCA

• What is it?1. Actions brought by the Department of Justice

2. Whistleblower or qui tam provisions allow individuals to bring actions in the name of the government, and can share in any recovery

Kulkarni Law Firm, PC

6

No specific intent to defraud must be proved

Page 7: Billing Compliance for Clinical Trials

What Matters -FCA

• “any person who—(A) knowingly presents, or causes to be presented, a false or fraudulent claim for payment or approval;

• (B) knowingly makes, uses, or causes to be made or used, a false record or statement material to a false or fraudulent claim; … “

Kulkarni Law Firm, PC

7

31 USC § 3729

“presents, or causes to be

presented a false.. claim”

“makes, uses, or causes to be made

or used, a false record…”

Page 8: Billing Compliance for Clinical Trials

Penalty & Damages - FCA … is liable to the United States Government for a civil penalty of not less than $5,500 and not more than $11,000, …, plus 3 times the amount of damages which the Government sustains because of the act of that person.”

Kulkarni Law Firm, PC

8

5500/ 11000

3x Govt. damages

Civil Penalty

Page 9: Billing Compliance for Clinical Trials

What Matters - FCA

• How can it be implicated?

Kulkarni Law Firm, PC

9

Double Billing

Misused Grants or

Deviations from

BudgetClaims for

services not rendered,

or not rendered as represented

Claims related to

the payment or receipt of a

kickbackRetaining

government funds when there is an obligation to repay

Informed consent

says patient won’t be charged

Page 10: Billing Compliance for Clinical Trials

Anti-kickback law• FCA• AKL• Stark• Park Doctrine• Planning• Future

Page 11: Billing Compliance for Clinical Trials

What Matters – Anti-Kickback Law

• How is it different from the FCA?

Kulkarni Law Firm, PC

11

No Private Right of Action

Page 12: Billing Compliance for Clinical Trials

Anti Kickback Law• Whoever knowingly and willfully solicits or receives any

remuneration (including any kickback, bribe, or rebate) directly or indirectly, overtly or covertly, in cash or in kind—(A) in return for referring an individual to a person for the furnishing or arranging for the furnishing of any item or service for which payment may be made in whole or in part under a Federal health care program, or

• (B) in return for purchasing, leasing, ordering, or arranging for or recommending purchasing, leasing, or ordering any good, facility, service, or item for which payment may be made in whole or in part under a Federal health care

Kulkarni Law Firm, PC

12

42 USC § 1320A–7B

…solicits or receives any remuneration..

…for furnishing or arranging.. Any item or service for which payment was made..

Page 13: Billing Compliance for Clinical Trials

Intent - AKL

“a person need not have actual knowledge of this section or specific intent to commit a violation of this section.”

Kulkarni Law Firm, PC

13

Page 14: Billing Compliance for Clinical Trials

Anti-Kickback Law - Penalties

“… shall be guilty of a felony and upon conviction thereof, shall be fined not more than $25,000 or imprisoned for not more than five years, or both.”

Kulkarni Law Firm, PC

14

$25000 Imprisonment = 5 years Penalties

Page 15: Billing Compliance for Clinical Trials

What Matters – Anti-Kickback Law

Kulkarni Law Firm, PC

15

Seeding Trials

Payments above FMV

Investigator Initiated Trials

Page 16: Billing Compliance for Clinical Trials

What Matters – Anti-Kickback Law

Kulkarni Law Firm, PC

16

FCA

Anti- Kickback

Page 17: Billing Compliance for Clinical Trials

Stark Law

• How many sites here are owned by Physicians who have separate practices?

• How many sites here are owned by Physicians whose own separate laboratories?

17

Kulkarni Law Firm, PC

Page 18: Billing Compliance for Clinical Trials

Stark Law

• Applies primarily to CROs, sites and physicians

• Technically a series of laws

• Governs self referral

Kulkarni Law Firm, PC

Page 19: Billing Compliance for Clinical Trials

What is Prohibited: Self Referral

• The physician may not make a referral to the entity for the furnishing of designated health services for which payment otherwise may be made under this title,

• Prohibits an entity from presenting a claim to Medicare or to any person or other entity for DHS provided under a prohibited referral.

42 U.S.C. 1395 Kulkarni Law Firm, PC

Page 20: Billing Compliance for Clinical Trials

Potential exposure

Page 21: Billing Compliance for Clinical Trials

Penalties

• No Medicare payment may be made for DHS rendered as a result of a prohibited referral;

• Entity must timely refund any amounts collected for DHS performed under a prohibited referral.

• Civil money penalties may also apply under some circumstances.

Kulkarni Law Firm, PC

Page 22: Billing Compliance for Clinical Trials

Some Potential Improper Arrangements

Referrals

Co-ownership of

PI and MD Office

Co-ownership of

offices and Central labs

Insufficient assessment

of FMV

Kulkarni Law Firm, PC

Page 23: Billing Compliance for Clinical Trials

Park Doctrine

23

Kulkarni Law Firm, PC

• FCA• AKL• Stark• Park Doctrine• Planning• Future

Page 24: Billing Compliance for Clinical Trials

Park Doctrine - Factors

• Individual’s position in the company • Relationship to the violation• Did the official have authority to correct or prevent

violation?• Knowledge of/actual participation in violation?

Kulkarni Law Firm, PC

Please let me know if you

want full list.

Page 25: Billing Compliance for Clinical Trials

Park Doctrine - Impact

Administrative Fines & Penalties

Criminal Fines

Civil Fines

Kulkarni Law Firm, PC

Page 26: Billing Compliance for Clinical Trials

Park Doctrine - What is it?

• Also called “Responsible Corporate Officer (RCO) Doctrine”

• RCO can be held liable for a first time misdemeanor (and subsequent felony) under the FD&C Act without proof of intent or negligence, even if no actual knowledge of or participation in specific offense 

Kulkarni Law Firm, PC

Page 27: Billing Compliance for Clinical Trials

Synthes - Impact

Monetary penalties: $22,500,000 (Norian) + $669,800 (Synthes)

Forfeiture of defendant Synthes

4 executives charged via Park Doctrine got 5-9 months in jail

Kulkarni Law Firm, PC

Page 28: Billing Compliance for Clinical Trials

Scott Harkonen - Impact

Convicted of wire fraud in September 2009

Fined $20,000

Sentenced to 6 months of home confinement

Kulkarni Law Firm, PC

Page 29: Billing Compliance for Clinical Trials

Penalties• FCA• AKL• Penalties• Planning• Future

Page 30: Billing Compliance for Clinical Trials

Administrative Penalties

Kulkarni Law Firm, PC

30

Public Relations Impact

Temporary Exclusions

Permanent Exclusions

Consent Decrees Fines

Page 31: Billing Compliance for Clinical Trials

Compliance planning• FCA• AKL• Stark• Park Doctrine• Planning• Future

Page 32: Billing Compliance for Clinical Trials

Compliance

Kulkarni Law Firm, PC

32

Compliance Officer/

CommitteeWritten Standards

Training Program

Report Overpayments

Provide OIG with annual compliance

reports

Restrict employment of ineligible

persons

Please contact me for a printable list

of factors

Page 33: Billing Compliance for Clinical Trials

Future• FCA• AKL• Stark• Park Doctrine• Planning• Future

Page 34: Billing Compliance for Clinical Trials

Future

• Impact of Physician Payment Sunshine Act

• Results reporting

• Franck's Pharmacy

Kulkarni Law Firm, PC

34

Financial ReportingClinical

trials.govRegulations v. Guidances

Page 35: Billing Compliance for Clinical Trials

Questions?

Darshan Kulkarni

Kulkarni Law Firm, PC

Ph: 215-703-7842

SLIDES MADE AVAILABLE.

@FDALawyers

www.kulkarnilawfirm.comKulkarni Law Firm, PC

35

Page 36: Billing Compliance for Clinical Trials

References

• http://www.taf.org/whyfca.htm• False Claims Act: 31 U.S.C. § 3729-3733 • Anti-Kickback Law: 42 U.S.C. § 1320a-7b(b) • False, Fictitious or Fraudulent Claims: 18 USC 287• http

://www.mintz.com/newsletter/2012/Advisories/1618-0112-NAT-HCED/1618-0112-NAT-HCED_index.pdf

Kulkarni Law Firm, PC

36